Naples Global Advisors’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-2,000
| Closed | -$243K | – | 407 |
|
|
2024
Q4 | $243K | Hold |
2,000
| – | – | 0.02% | 369 |
|
|
2024
Q3 | $250K | Hold |
2,000
| – | – | 0.02% | 368 |
|
|
2024
Q2 | $316K | Hold |
2,000
| – | – | 0.03% | 333 |
|
|
2024
Q1 | $259K | Buy |
+2,000
| New | +$259K | 0.03% | 362 |
|
|
2023
Q4 | – | Sell |
-2,000
| Closed | -$242K | – | 419 |
|
|
2023
Q3 | $242K | Hold |
2,000
| – | – | 0.03% | 360 |
|
|
2023
Q2 | $229K | Hold |
2,000
| – | – | 0.03% | 369 |
|
|
2023
Q1 | $276K | Hold |
2,000
| – | – | 0.03% | 345 |
|
|
2022
Q4 | $259K | Hold |
2,000
| – | – | 0.03% | 347 |
|
|
2022
Q3 | $221K | Buy |
+2,000
| New | +$221K | 0.03% | 351 |
|
|
2021
Q1 | – | Sell |
-2,000
| Closed | -$341K | – | 373 |
|
|
2020
Q4 | $341K | Hold |
2,000
| – | – | 0.06% | 288 |
|
|
2020
Q3 | $281K | Hold |
2,000
| – | – | 0.05% | 289 |
|
|
2020
Q2 | $321K | Buy |
+2,000
| New | +$321K | 0.07% | 269 |
|
|
2020
Q1 | – | Sell |
-2,000
| Closed | -$258K | – | 332 |
|
|
2019
Q4 | $258K | Buy |
+2,000
| New | +$258K | 0.05% | 285 |
|
|
2019
Q3 | – | Sell |
-2,000
| Closed | -$304K | – | 319 |
|
|
2019
Q2 | $304K | Hold |
2,000
| – | – | 0.07% | 261 |
|
|
2019
Q1 | $238K | Hold |
2,000
| – | – | 0.06% | 272 |
|
|
2018
Q4 | $237K | Hold |
2,000
| – | – | 0.07% | 269 |
|
|
2018
Q3 | $323K | Hold |
2,000
| – | – | 0.09% | 249 |
|
|
2018
Q2 | $264K | Buy |
+2,000
| New | +$264K | 0.07% | 266 |
|